Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04160494
Title D2C7-IT With Atezolizumab for Recurrent Gliomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Darell D. Bigner, MD, PhD
Indications

high grade glioma

Therapies

Atezolizumab + D2C7-IT

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.